epilepsy

Early identification of refractory epilepsy.

Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314-9. DOI: 10.1056/NEJM200002033420503. PubMed PMID: 10660394.

SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.

Haerian BS, Baum L, Kwan P, Tan HJ, Raymond AA, Mohamed Z. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis. Pharmacogenomics. 2013;14(10):1153-66. DOI: 10.2217/pgs.13.104. PubMed PMID: 23859570.

Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients.

Nakajima Y, Saito Y, Shiseki K, Fukushima-Uesaka H, Hasegawa R, Ozawa S, et al. Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients. Eur J Clin Pharmacol. 2005;61(1):25-34. DOI: 10.1007/s00228-004-0878-1. PubMed PMID: 15692831.

Genetic variants in microsomal epoxide hydrolase influence carbamazepine dosing.

Makmor-Bakry M, Sills GJ, Hitiris N, Butler E, Wilson EA, Brodie MJ. Genetic variants in microsomal epoxide hydrolase influence carbamazepine dosing. Clin Neuropharmacol. 2009;32(4):205-12. DOI: 10.1097/WNF.0b013e318187972a. PubMed PMID: 19620853.

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.

Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol. 2011;10(7):609-17. DOI: 10.1016/S1474-4422(11)70107-7. PubMed PMID: 21652013.

Antiepileptic drugs: indications other than epilepsy.

Spina E, Perugi G. Antiepileptic drugs: indications other than epilepsy. Epileptic Disord. 2004;6(2):57-75. PubMed PMID: 15246950.

Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine.

Miller AD, Krauss GL, Hamzeh FM. Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine. Acta Neurol Scand. 2004;109(6):374-7. DOI: 10.1111/j.1600-0404.2004.00291.x. PubMed PMID: 15147458.

Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.

Perucca E, Cloyd J, Critchley D, Fuseau E. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Epilepsia. 2008;49(7):1123-41. DOI: 10.1111/j.1528-1167.2008.01665.x. PubMed PMID: 18503564.

Clinical pharmacology of antiepileptic drugs.

Bazil CW, Pedley TA. Clinical pharmacology of antiepileptic drugs. Clin Neuropharmacol. 2003;26(1):38-52. PubMed PMID: 12567163.

Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.

McAuley JW, Anderson GD. Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. Clin Pharmacokinet. 2002;41(8):559-79. DOI: 10.2165/00003088-200241080-00002. PubMed PMID: 12102641.